Table 1.
Parameters | All participants (n = 42) |
---|---|
Age, years | 55.0 ± 10.6 |
Gender, male/female | 25/17 |
Height, m | 1.62 ± 0.09 |
Weight, kg | 63.9 ± 9.5 |
Body mass index, kg/m2 | 24.2 ± 2.7 |
Body surface area, m2 | 1.68 ± 0.16 |
Systolic blood pressure, mmHg | 119.4 ± 13.8 |
Diastolic blood pressure, mmHg | 77.6 ± 9.4 |
Heart rate, bpm | 73.6 ± 11.0 |
Ejection fraction, % | 58.5 ± 7.3 |
End-diastolic volume index, ml/m2 | 70.4 ± 12.7 |
End-systolic volume index, ml/m2 | 29.5 ± 10.1 |
Stroke volume index, ml/m2 | 40.9 ± 7.6 |
Cardiac index, l/min/m2 | 2.99 ± 0.59 |
Myocardial mass index, g/m2 | 57.9 ± 13.4 |
Hematocrit, % | 39.8 ± 3.4 |
Late gadolinium enhancement positive, n (%) | 7 (16.7) |
Data were presented as mean ± standard deviation.
Total number: type 2 diabetes mellitus (T2DM) without hypertension (HT) (n = 19), T2DM with HT (n = 5), HT (n = 2), healthy volunteers (n = 7), hypertrophic cardiomyopathy (n = 4), cardiac amyloidosis (n = 1), chronic myocardial infarction (n = 1), left ventricular noncompaction (n = 1), dilated cardiomyopathy (n = 1), arrhythmogenic right ventricular cardiomyopathy (n = 1).